Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Cherrier, K. Anderson, J. Shofer, S. Millard, A. Matsumoto (2015)
Testosterone Treatment of Men With Mild Cognitive Impairment and Low Testosterone LevelsAmerican Journal of Alzheimer's Disease & Other Dementias, 30
V. Muraleedharan, H. Marsh, D. Kapoor, K. Channer, T. Jones (2013)
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.European journal of endocrinology, 169 6
G. Alexander, Geetha Iyer, Eleanor Lucas, D. Lin, Sonal Singh (2016)
Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis.The American journal of medicine, 130 3
G. Rastrelli, Lara Giovannini, A. Calogero, D. Gianfrilli, E. Serra, A. Pizzocaro, V. Giagulli, Giovanna Motta, G. Vancieri, A. Sperandio, S. Andò, R. Selice, G. Luca, F. Cocchiara, D. Canale, Mario Maggi (2016)
Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registryJournal of Endocrinological Investigation, 39
R. Ramasamy, Jason Scovell, Michael Mederos, R. Ren, Lakshay Jain, L. Lipshultz (2015)
Association Between Testosterone Supplementation Therapy and Thrombotic Events in Elderly Men.Urology, 86 2
A. Bello, P. Stenvinkel, Meng Lin, B. Hemmelgarn, R. Thadhani, S. Klarenbach, Christopher Chan, D. Zimmerman, G. Cembrowski, G. Strippoli, J. Carrero, M. Tonelli (2014)
Serum testosterone levels and clinical outcomes in male hemodialysis patients.American journal of kidney diseases : the official journal of the National Kidney Foundation, 63 2
G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, P. Wilkinson (2013)
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.The journal of sexual medicine, 10 6
H. Schneider, H. Wallaschofski, H. Völzke, M. Markus, M. Doerr, S. Felix, M. Nauck, N. Friedrich (2012)
Incremental Effects of Endocrine and Metabolic Biomarkers and Abdominal Obesity on Cardiovascular Mortality PredictionPLoS ONE, 7
M. Shores, M. Biggs, A. Arnold, N. Smith, W. Longstreth, J. Kizer, C. Hirsch, A. Cappola, A. Matsumoto (2014)
Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study.The Journal of clinical endocrinology and metabolism, 99 6
Kerry Hildreth, D. Barry, K. Moreau, Joseph Griend, R. Meacham, Tammie Nakamura, P. Wolfe, W. Kohrt, J. Ruscin, J. Kittelson, M. Cress, R. Ballard, R. Schwartz (2013)
Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels.The Journal of clinical endocrinology and metabolism, 98 5
S. Janjgava, T. Zerekidze, L. Uchava, E. Giorgadze, K. Asatiani (2014)
Macedonian Journal of Medical Sciences
Lin Xu, G. Freeman, B. Cowling, C. Schooling, C. Schooling (2013)
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trialsBMC Medicine, 11
S. Borst, J. Shuster, Baiming Zou, F. Ye, H. Jia, A. Wokhlu, J. Yarrow (2014)
Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysisBMC Medicine, 12
G. Corona, V. Giagulli, E. Maseroli, L. Vignozzi, A. Aversa, M. Zitzmann, F. Saad, E. Mannucci, M. Maggi (2016)
Testosterone supplementation and body composition: results from a meta-analysis of observational studiesJournal of Endocrinological Investigation, 39
S. Albert, J. Morley (2016)
Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic reviewClinical Endocrinology, 85
W. Finkle, S. Greenland, Gregory Ridgeway, J. Adams, M. Frasco, M. Cook, J. Fraumeni, R. Hoover (2014)
Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in MenPLoS ONE, 9
S. Pye, Ilpo Huhtaniemi, J. Finn, David Lee, Terence O'Neill, A. Tajar, G. Bártfai, Steven Boonen, F. Casanueva, G. Forti, Aleksander Giwercman, Thang Han, K. Kula, Michael Lean, Neil Pendleton, M. Punab, Martin Rutter, D. Vanderschueren, F. Wu (2014)
Late-onset hypogonadism and mortality in aging men.The Journal of clinical endocrinology and metabolism, 99 4
C. Wallis, K. Lo, Yuna Lee, Y. Krakowsky, A. Garbens, R. Satkunasivam, S. Herschorn, R. Kodama, P. Cheung, S. Narod, R. Nam (2016)
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.The lancet. Diabetes & endocrinology, 4 6
L. Mosca, E. Barrett-Connor, N. Wenger (2011)
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes.Circulation, 124 19
S. Humphries (2017)
Common Variants for Cardiovascular Disease: Clinical Utility ConfirmedCirculation, 135
G. Corona, G. Rastrelli, M. Monami, C. Melani, D. Balzi, A. Sforza, G. Forti, E. Mannucci, M. Maggi (2011)
Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction.The journal of sexual medicine, 8 7
E. Gianatti, P. Dupuis, R. Hoermann, B. Strauss, J. Wentworth, J. Zajac, M. Grossmann (2014)
Effect of Testosterone Treatment on Glucose Metabolism in Men With Type 2 Diabetes: A Randomized Controlled TrialDiabetes Care, 37
D. Riche, W. Baker, C. Koch (2014)
Deaths and cardiovascular events in men receiving testosterone.JAMA, 311 9
S. Basaria, T. Travison, Daniel Alford, P. Knapp, Kjersten Teeter, C. Cahalan, Richard Eder, Kishore Lakshman, Eric Bachman, George Mensing, M. Martel, Dillon Le, Helene Stroh, S. Bhasin, A. Wasan, R. Edwards (2015)
Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trialPAIN, 156
Prita Asih, E. Wahjoepramono, Vilia Aniwiyanti, L. Wijaya, K. Ruyck, K. Taddei, S. Fuller, H. Sohrabi, S. Dhaliwal, G. Verdile, M. Carruthers, R. Martins (2015)
Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety.CNS & neurological disorders drug targets, 14 5
K. Khurana, S. Navaneethan, S. Arrigain, J. Schold, J. Nally, D. Shoskes (2014)
Serum testosterone levels and mortality in men with CKD stages 3-4.American journal of kidney diseases : the official journal of the National Kidney Foundation, 64 3
H. Pope, R. Wood, A. Rogol, F. Nyberg, L. Bowers, S. Bhasin (2014)
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.Endocrine reviews, 35 3
S. Dhindsa, H. Ghanim, M. Batra, Nitesh Kuhadiya, S. Abuaysheh, S. Sandhu, K. Green, A. Makdissi, J. Hejna, A. Chaudhuri, M. Punyanitya, P. Dandona (2015)
Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes, 39
I. Velho, T. Fighera, P. Ziegelmann, P. Spritzer (2017)
Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic reviewAndrology, 5
S. Page (2014)
Testosterone, cardiovascular disease, and mortality in men: living in the dark.The lancet. Diabetes & endocrinology, 2 8
A. Araujo, J. Dixon, Elizabeth Suarez, M. Murad, L. Guey, G. Wittert (2011)
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology and Metabolism, 96
G. Corona, E. Maseroli, M. Maggi (2014)
Injectable testosterone undecanoate for the treatment of hypogonadismExpert Opinion on Pharmacotherapy, 15
G. Corona, M. Dicuio, G. Rastrelli, E. Maseroli, F. Lotti, A. Sforza, M. Maggi (2017)
Testosterone treatment and cardiovascular and venous thromboembolism risk: what is ‘new’?Journal of Investigative Medicine, 65
G. Corona, G. Rastrelli, M. Monami, A. Guay, Jaques Buvat, A. Sforza, G. Forti, E. Mannucci, M. Maggi (2011)
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study.European journal of endocrinology, 165 5
T. Cheetham, J. An, S. Jacobsen, F. Niu, S. Sidney, C. Quesenberry, S. Vandeneeden (2017)
Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen DeficiencyJAMA Internal Medicine, 177
O. Onasanya, Geetha Iyer, Eleanor Lucas, D. Lin, Sonal Singh, G Alexander (2016)
Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews.The lancet. Diabetes & endocrinology, 4 11
S. Borst, J. Yarrow, Christine Conover, U. Nseyo, J. Meuleman, Judyta Lipinska, R. Braith, Darren Beck, Jeffrey Martin, Matthew Morrow, S. Roessner, L. Beggs, S. McCoy, Darryl Cannady, J. Shuster (2014)
Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.American journal of physiology. Endocrinology and metabolism, 306 4
G. Corona, E. Maseroli, G. Rastrelli, A. Isidori, A. Sforza, E. Mannucci, M. Maggi (2014)
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysisExpert Opinion on Drug Safety, 13
M. Shores, N. Smith, C. Forsberg, B. Anawalt, A. Matsumoto (2012)
Testosterone treatment and mortality in men with low testosterone levels.The Journal of clinical endocrinology and metabolism, 97 6
M. Fernández-Balsells, M. Murad, Melanie Lane, Juliana Lampropulos, F. Albuquerque, R. Mullan, Neera Agrwal, Mohamed Elamin, J. Gallegos-Orozco, Amy Wang, Patricia Erwin, S. Bhasin, V. Montori (2010)
Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.The Journal of clinical endocrinology and metabolism, 95 6
A. Seftel (2015)
Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.The Journal of urology, 194 3
R. Tan, Kelly Cook, William Reilly (2015)
Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable TestosteroneInternational Journal of Endocrinology, 2015
Luigi Bartalena, F. Bogazzi, S. Brogioni, Lucia Grasso, E. Martino (1998)
Role of cytokines in the pathogenesis of the euthyroid sick syndrome.European journal of endocrinology, 138 6
G. Corona, V. Giagulli, E. Maseroli, L. Vignozzi, A. Aversa, M. Zitzmann, F. Saad, E. Mannucci, M. Maggi (2016)
THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study.European journal of endocrinology, 174 3
M. Eisenberg, Shufeng Li, Danielle Herder, D. Lamb, L. Lipshultz (2014)
Testosterone Therapy and Mortality RiskInternational journal of impotence research, 27
R. Srinath, Sherita Golden, K. Carson, A. Dobs (2015)
Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study.The Journal of clinical endocrinology and metabolism, 100 4
R. Vigen, Colin O’Donnell, A. Baron, G. Grunwald, T. Maddox, S. Bradley, A. Barqawi, Glenn Woning, M. Wierman, M. Plomondon, J. Rumsfeld, P. Ho (2013)
Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.JAMA, 310 17
S. Basaria, S. Harman, T. Travison, H. Hodis, P. Tsitouras, M. Budoff, K. Pencina, J. Vita, C. Dzekov, N. Mazer, N. Mazer, A. Coviello, P. Knapp, K. Hally, Emma Pinjić, Mingzhu Yan, T. Storer, S. Bhasin (2015)
Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.JAMA, 314 6
Zoë Hyde, P. Norman, L. Flicker, G. Hankey, Osvaldo Almeida, Osvaldo Almeida, K. McCaul, S. Chubb, B. Yeap (2012)
Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study.The Journal of clinical endocrinology and metabolism, 97 1
G. Jasuja, S. Bhasin, J. Reisman, J. Hanlon, Donald Miller, Anthony Morreale, L. Pogach, F. Cunningham, Angela Park, D. Berlowitz, A. Rose (2017)
Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional StudyJournal of General Internal Medicine, 32
G. Corona, E. Maseroli, G. Rastrelli, D. Francomano, A. Aversa, G. Hackett, S. Ferri, A. Sforza, M. Maggi (2016)
Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden?Minerva endocrinologica, 41 2
G. Corona, G. Rastrelli, E. Maseroli, N. Fralassi, A. Sforza, G. Forti, E. Mannucci, M. Maggi (2014)
Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular eventsAndrology, 2
G. Corona, M. Maggi (2015)
Testosterone supplementation and cardiovascular risk.Trends in cardiovascular medicine, 25 3
G. Brock, D. Heiselman, M. Maggi, S. Kim, J. Vallejo, H. Behre, J. McGettigan, S. Dowsett, R. Hayes, J. Knorr, X. Ni, K. Kinchen (2016)
Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study.The Journal of urology, 195 3
E. Lerchbaum, S. Pilz, B. Boehm, T. Grammer, B. Obermayer-Pietsch, W. März (2012)
Combination of low free testosterone and low vitamin D predicts mortality in older men referred for coronary angiographyClinical Endocrinology, 77
M. Maggio, P. Snyder, G. Ceda, Y. Milaneschi, M. Luci, C. Cattabiani, S. Masoni, A. Vignali, R. Volpi, F. Lauretani, H. Peachey, G. Valenti, A. Cappola, D. Longo, L. Ferrucci (2013)
Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older menAndrology, 1
J. Ruige, A. Mahmoud, D. Bacquer, J. Kaufman (2010)
Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysisHeart, 97
D. Paduch, P. Polzer, X. Ni, S. Basaria (2015)
Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial.The Journal of clinical endocrinology and metabolism, 100 8
G. Corona, L. Vignozzi, A. Sforza, E. Mannucci, M. Maggi (2015)
Obesity and late-onset hypogonadismMolecular and Cellular Endocrinology, 418
G. Corona, A. Sforza, M. Maggi (2017)
Testosterone Replacement Therapy: Long-Term Safety and EfficacyThe World Journal of Men's Health, 35
A. Traish, R. Feeley, A. Guay (2009)
Mechanisms of obesity and related pathologies: Androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunctionThe FEBS Journal, 276
Véronique Soisson, S. Brailly‐Tabard, C. Helmer, O. Rouaud, M. Ancelin, Chahinez Zerhouni, A. Guiochon‐Mantel, P. Scarabin (2013)
A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study.Maturitas, 75 3
G. Corona, S. Cipriani, G. Rastrelli, A. Sforza, E. Mannucci, M. Maggi (2016)
High Triglycerides Predicts Arteriogenic Erectile Dysfunction and Major Adverse Cardiovascular Events in Subjects With Sexual Dysfunction.The journal of sexual medicine, 13 9
Rudy Haddad, C. Kennedy, S. Caples, M. Tracz, Enrique Boloña, K. Sideras, Maria Uraga, P. Erwin, V. Montori (2007)
Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.Mayo Clinic proceedings, 82 1
A. Traish, A. Haider, K. Haider, G. Doros, F. Saad (2017)
Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with HypogonadismJournal of Cardiovascular Pharmacology and Therapeutics, 22
K. Cheung, E. Lau, W. So, R. Ma, R. Ozaki, A. Kong, F. Chow, J. Chan, A. Luk (2017)
Low testosterone and clinical outcomes in Chinese men with type 2 diabetes mellitus - Hong Kong Diabetes Registry.Diabetes research and clinical practice, 123
A. Morgentaler (2014)
Testosterone, cardiovascular risk, and hormonophobia.The journal of sexual medicine, 11 6
J. Chillarón, Mercè Fernández-Miró, M. Albareda, S. Fontserè, C. Colom, L. Vila, J. Pedro-botet, J. Le-Roux (2016)
Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.Endocrine journal, 63 9
J. Baillargeon, R. Urban, Y. Kuo, K. Ottenbacher, M. Raji, Fei Du, Yu-Li Lin, J. Goodwin (2014)
Risk of Myocardial Infarction in Older Men Receiving Testosterone TherapyAnnals of Pharmacotherapy, 48
A. Morelli, E. Sarchielli, P. Comeglio, S. Filippi, L. Vignozzi, M. Marini, G. Rastrelli, E. Maneschi, I. Cellai, L. Persani, L. Adorini, G. Vannelli, M. Maggi (2014)
Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbitsMolecular and Cellular Endocrinology, 382
C. Hoyos, B. Yee, C. Phillips, E. Machan, R. Grunstein, Peter Liu (2012)
Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.European journal of endocrinology, 167 4
D. Glintborg, L. Christensen, T. Kvorning, Rasmus Larsen, K. Højlund, K. Brixen, D. Hougaard, A. Handberg, M. Andersen (2015)
Differential effects of strength training and testosterone treatment on soluble CD36 in aging men: Possible relation to changes in body compositionScandinavian Journal of Clinical and Laboratory Investigation, 75
J. Brand, M. Rovers, B. Yeap, Harald Schneider, T. Tuomainen, R. Haring, G. Corona, A. Onat, M. Maggio, C. Bouchard, Peter Tong, Richard Chen, M. Akishita, J. Gietema, M. Gannagé-Yared, A. Undén, A. Hautanen, Nicolai Goncharov, P. Kumanov, S. Chubb, Osvaldo Almeida, H. Wittchen, J. Klotsche, H. Wallaschofski, H. Völzke, J. Kauhanen, J. Salonen, L. Ferrucci, Y. Schouw (2014)
Testosterone, Sex Hormone-Binding Globulin and the Metabolic Syndrome in Men: An Individual Participant Data Meta-Analysis of Observational StudiesPLoS ONE, 9
J. Veldhuis, Rebecca Yang, F. Roelfsema, P. Takahashi (2016)
Proinflammatory Cytokine Infusion Attenuates LH's Feedforward on Testosterone Secretion: Modulation by Age.The Journal of clinical endocrinology and metabolism, 101 2
M. Etminan, S. Skeldon, S. Goldenberg, B. Carleton, J. Brophy (2015)
Testosterone Therapy and Risk of Myocardial Infarction: A Pharmacoepidemiologic StudyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 35
M. Maggi, Frederick Wu, T. Jones, G. Jackson, H. Behre, G. Hackett, A. Martín-Morales, G. Balercia, A. Dobs, S. Arver, M. Maggio, G. Cunningham, A. Isidori, R. Quinton, Olivia Wheaton, F. Siami, R. Rosen (2016)
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)International Journal of Clinical Practice, 70
Peter Snyder, S. Bhasin, G. Cunningham, A. Matsumoto, A. Stephens-Shields, J. Cauley, Thomas Gill, E. Barrett-Connor, R. Swerdloff, R. Swerdloff, Christina Wang, Christina Wang, K. Ensrud, Cora Lewis, John Farrar, D. Cella, Raymond Rosen, M. Pahor, Jill Crandall, M. Molitch, Denise Cifelli, Darlene Dougar, Laura Fluharty, Susan Resnick, T. Storer, S. Anton, S. Basaria, S. Diem, X. Hou, Emile Mohler, J. Parsons, N. Wenger, B. Zeldow, J. Landis, S. Ellenberg (2016)
Effects of Testosterone Treatment in Older Men.The New England journal of medicine, 374 7
O. Calof, Atam Singh, Martin Lee, A. Kenny, R. Urban, J. Tenover, S. Bhasin (2005)
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.The journals of gerontology. Series A, Biological sciences and medical sciences, 60 11
H. Behre, T. Tammela, S. Arver, J. Tolrà, V. Bonifacio, M. Lamche, Judy Kelly, F. Hiemeyer, E. Giltay, L. Gooren (2012)
A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-upThe Aging Male, 15
Rishi Sharma, Olurinde Oni, K. Gupta, Guoqing Chen, Mukut Sharma, B. Dawn, Ramratan Sharma, D. Parashara, V. Savin, J. Ambrose, Rajat Barua (2015)
Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.European heart journal, 36 40
M. Budoff, S. Ellenberg, C. Lewis, E. Mohler, N. Wenger, S. Bhasin, E. Barrett-Connor, R. Swerdloff, A. Stephens-Shields, J. Cauley, J. Crandall, G. Cunningham, K. Ensrud, T. Gill, A. Matsumoto, M. Molitch, R. Nakanishi, N. Nezarat, Suguru Matsumoto, Xiaoling Hou, S. Basaria, S. Diem, Christina Wang, Denise Cifelli, P. Snyder (2017)
Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low TestosteroneJAMA, 317
R. Haring, Zhaoyang Teng, V. Xanthakis, A. Coviello, L. Sullivan, S. Bhasin, J. Murabito, H. Wallaschofski, R. Vasan (2013)
Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all‐cause mortality in elderly men from the Framingham Heart StudyClinical Endocrinology, 78
Curr Sex Health Rep (2017) 9:277–289 https://doi.org/10.1007/s11930-017-0132-3 MEDICAL COMORBIDITIES (M MINER, S PARISH AND A GOLDSTEIN, SECTION EDITORS) Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years 1 2 3 1 Giovanni Corona & Giulia Rastrelli & Mauro Dicuio & Alessandra Sforza & Mario Maggi Published online: 16 November 2017 Springer Science+Business Media, LLC 2017 Abstract protective role of TTh on CV risk; however, data from RCTs Purpose of the Review The relationship between the age- and their meta-analysis, presented here, do not provide us with dependent decline of testosterone (T) and cardiovascular sufficient information on this point. (CV) risk in men is still a matter of intense debate. In particular, Summary Present data do not indicate an increased risk with over the last 5 years, several scientific reports have shed a new TTh, but there is also insufficient definitive evidence that TTh negative light on the association between T treatment (TTh) is protective. Therefore, further and more specific trials are and forthcoming CV diseases (CVD). Based on this evidence, advisable to better clarify the possible relationship between the US Food and Drug Administration agency has recom- low T, TTh, and CVD in aging
Current Sexual Health Reports – Springer Journals
Published: Nov 16, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.